S.1. Assessments

S.1.1. Rating Scales
The Bush-Francis Catatonia Rating Scale (BFCRS) was developed as a catatonia rating scale which includes a 14-item screening tool and a 23-item rating tool [46, 47] . Two positive findings on the screening are required to suggest the diagnosis of catatonia, while the rating scale establishes the severity of symptoms [46] . In a review of six rating scales for catatonia, the BFCRS was the most highly recommended [48] .
The Abnormal Involuntary Movement Scale (AIMS) was developed to assess dyskinetic movements by scoring orofacial movements, extremity and truncal dyskinesias [49] .
S.1.2. Laboratory Studies
Supplementary Table S1 provides the limited laboratory studies from prior private psychiatric hospital admissions. Supplementary Table S2 describes the routine laboratory studies conducted at the state psychiatric hospital; the more complex studies including hormones were sent out to a contracted commercial laboratory. Table 2 provides a very brief summary of Supplementary Table S2.
Supplementary Table S3 summarizes the descriptive analyses of the biological variables measured during the second catatonic episode. The patient's creatine kinase (CK) was checked when the patient was at the state psychiatric hospital but was not measured during the periods of convalescent leave in which the patient was living in her own apartment. CK elevations have been described in patients with catatonia [50] ; furthermore, the senior author uses CK to longitudinally monitor the severity of catatonia in his patients [51, 52] . Lactate dehydrogenase (LDH) was also measured as a marker of muscle damage, but the literature indicates that LDH is less sensitive than CK [53] .
During the first catatonic episode the patient had several abnormally high values of glucose, cholesterol, and white blood cell (WBC) count that were compatible with hypercortisolemia. With the onset of the second episode, afternoon (3 PM) cortisol was used to establish hypercortisolemia. Female 3 sexual hormones including progesterone, estradiol, follicle stimulating hormone (FSH), and luteinizing hormone (LH) were also collected to establish menopause, but the data is not presented.
S.1.3. Menstruation
Day 1 of the menstrual cycle is defined by the initiation of menstrual flow, or menses. Menstruation or menstrual spotting was established by nursing staff and patient report during and after the first catatonic episode in the long-term unit, and by family and the patient when she was not hospitalized.
S2. Statistics
The Statistical Package for the Social Sciences (SPSS 23) was used to analyze the data. There is a long tradition in psychology of analyzing case reports with statistical methods [54] [55] [56] , which is slowly moving to medicine [57] . There is no general agreement on which is the best method for establishing significant differences, and one of the major problems is that some but not all of the data from single cases can show serial dependence due to the temporal order of sequence [57] . This serial dependence can be tested using the module of autocorrelation in SPSS, which tests autocorrelations using the significance of the BoxLjung statistics and provides partial correlations with their upper and lower limits of their confidence intervals.
S.2.1. Descriptive Analyses
The upper panel of Supplementary Table S3 describes the means, standard deviations (SDs), medians, and percentages of abnormal values of the laboratory variables: WBC, absolute neutrophil count (ANC), platelet count, CK, LDH, and cortisol, during the second catatonic episode. There were 46 days when the values of WBC, CK, LDH, and cortisol were recorded together with status of the menses during the second catatonic episode. After dichotomizing the menses into two groups of "yes" and "no," with "light flow" or "spotting" included in the "yes" category, the values of these variables were dichotomized into two groups of "normal" and "abnormal" using the recommended laboratory ranges. 
S.2.3. Testing for Autocorrelation before Testing for Significance
Then, using the SPSS autocorrelation module, we planned to verify that the assumption of independent observations is not violated before any statistical test could be used to explore significant differences after stratification.
S.2.4. Multiple Linear Regression Model for LDH
A linear regression model with LDH as the dependent variable was planned to explore whether it was associated with CK, WBC and cortisol. We planned to use the Box-Ljung tests for autocorrelation and partial autocorrelation functions to verify the lack of evidence in the standardized residual set for serial autocorrelations or complex time series structure [58, 59] .
S.3. Periods between Catatonic Episodes
S.3.1. Period between First and Second Catatonic Episodes (4.5 Months)
The patient became stable with no catatonic symptoms on the combination of 20 mg/day of olanzapine, 1 mg/day of clonazepam, and 6 mg/day of lorazepam. After two successful home visits, she was placed on convalescent leave on day 264 with the same medications. On day 297 the patient came to the hospital for follow-up. She had no catatonic symptoms but she had mild dyskinetic movements in several areas (lips, jaw, tongue and upper extremities) on AIMS. As she had gone through three menstrual cycles without any catatonic exacerbations, olanzapine was decreased and finally stopped on day 324. On day 328, during a second hospital follow-up, the patient showed no worsening of the psychotic symptoms after stopping the olanzapine and no catatonic symptoms, but she had an exacerbation of the dyskinetic movements on the AIMS (face with no movements, lips mild, jaw moderate, tongue moderate, upper extremities moderate, lower extremities mild and trunk none).
S.3.2. Period between Second and Third Catatonic Episodes (12 months)
Once the patient experienced a resolution of her catatonic symptoms, she was placed on convalescent leave. On day 1029 she ran out of her lorazepam and had withdrawal seizures four days later, but this did not trigger any catatonia. She was kept stable on 6 mg/day of lorazepam and outpatient maintenance electroconvulsive therapy (ECT) every 4 weeks at an academic general hospital.
S.3.3. Period between Third and Fourth Catatonic Episodes (9 months)
During this time of convalescent leave, the patient had no symptoms of catatonia on maintenance treatment with 6 mg/day of lorazepam and ECT every 4 weeks. The patient continued to do well through two later cycles of menses, which then became irregular. Her last known menses occurred 4 years and 1 month after admission.
S.4. Outcome after the State Psychiatric Hospital Admission
The patient was maintained on monthly outpatient ECT at the university hospital for 4 years until age 56 with no admissions. At age 59 she was admitted to a community hospital with a catatonic relapse for 13 days. When CK elevation was observed, she was transferred to the university hospital due to the possibility of neuroleptic malignant syndrome (NMS). At the university hospital, she was initially treated with bromocriptine and then transferred to the psychiatry department where she recovered with 6 ECTs and lorazepam 3 mg/day. After 52 days she was discharged on ECT every 3 weeks, lorazepam 2 mg/day and clozapine 150 mg/day (Supplementary Table S1 ). Then she was decreased to monthly ECT. The last ECT was given at age 60, at which time she had had 2249 days or 7 years of follow-up after the state psychiatric admission. The patient did not come back for the next monthly ECT. A sudden cardiac death 6 cannot be ruled out since she had recently been seen at the outpatient cardiology department of the university hospital, but the records are no longer available.
S.5. Additional Biological Abnormalities
S.5.1. Platelet Elevations S.5.1.1. Data from the State Psychiatric Hospital. At the state psychiatric hospital, during the first catatonic episode, the patient's platelets were elevated at the peak of catatonic symptoms. During the second catatonic episode, platelets were always elevated except for one value. The first peak in platelets to a value >700,000/mm 3 occurred on day 371, while the patient was having her menses. Platelets also peaked around day 400 to day 407, with values as high as 888,000/mm 3 . These latter values occurred after her menses but labs were not drawn during the first seven days of this menstrual cycle. The third peak in platelet count occurred around days 435 to 448, with a maximum of 861,000/mm 3 measured, although platelets were checked only twice during this time. Platelet count started to decrease around day 617 and continued to decrease until the end of the second catatonic episode.
During the third catatonic episode, platelets were not measured for the first four days of the episode. Afterward, most values were within the hospital's standard range during this short episode (14 days). Platelet count was not measured during the fourth catatonic episode.
The patient refused to go to the academic general hospital to be studied for her abnormal platelet count, but she agreed that her medical data could be sent to internal medicine for evaluation. The internist recommended consideration of a bone marrow biopsy but the patient adamantly refused. The psychiatrists and the patient's family agreed that a high platelet count was a minor issue compared with the risk of untreated catatonia and did not insist on the bone marrow biopsy.
S.5.1.2. Data from the Prior Psychiatric Admissions.
The documentation from the private psychiatric hospitals provided little relevant information on platelet count, merely mild elevations during the sixth and tenth admissions (Footnotes 8 and 11 of Supplementary Table S1). 7 S.5.1.3. Data from the Later Psychiatric Admissions. The university hospital described a mild platelet elevation during admission 20 (Footnote 18, Supplementary Table S1).
S.5.2. Iron Supplementation
Iron and total iron binding concentration (TIBC) were within normal limits, but there was a low percentage of iron saturation and of low serum ferritin; thus, iron supplementation of 975 mg ferrous sulfate was added from day 622 to day 1111. Three months after starting the iron treatment, the percentage saturation remained low at 10% while the ferritin had corrected. However, this was not associated with any clinical improvement in catatonia; that did not occur until ECT was added. Between the second and third catatonic episodes, all values from the iron studies became essentially normal and iron supplementation was discontinued on day 1111. She had no prior psychiatric admissions, and on admission she was not taking any psychiatric medications. LDH was documented as elevated, although the exact value was not available.
10
Free cortisol level of 117 mcg/24 h was documented, and the cortisol DST was described as abnormal at 14.7 mcg/dL.
11
LDH=733 U/L. The explanation provided for LDH in the discharge summary was bruising present at admission. Platelets = 480,000/mm 3 . She was diagnosed with mania, although severe agitation during a catatonic episode is suspected by us.
12
Discharge summary was not available. The discharge summary from hospitalization #17 states she was delusional, had catatonic behavior, and her antipsychotic medications were adjusted during hospitalization #16.
13
Documented as: combative, withdrawn, and the family found her standing non-communicative in the shower during her menses.
14
The patient was noted to have "an elevated white count" that "dropped to 11.1 eventually", suggesting that earlier in the admission the WBC was elevated. Additionally, she had an elevated glucose of 142 mg/dL.
CK=1800 U/L 16
The patient was first admitted to neurology for 9 days (days 3807 to 3815) and treated for neuroleptic malignant syndrome with bromocriptine. She was unresponsive to the lorazepam challenge. On day 3815 the patient was transferred to psychiatry as the CK elevation was considered secondary to catatonia.
17
She received 6 ECTs for acute treatment. She was discharged with ECT every 3 weeks as maintenance treatment which was later decreased to every month. . There were also elevations of CRP 69 mg/dL (normal range 0-0.9) and ESR 45 mm/hr (normal range 0-11). Initially she also had a urinary tract infection but blood cultures were negative. Before discharge her last WBC=13.2 x 10 Supplementary 
